0240-OL:HK:HK-BUILD KING HOLD (HKD)

COMMON STOCK | Other |

Last Closing

USD 0.95

Change

-0.02 (-2.06)%

Market Cap

N/A

Volume

0.85M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 0240-OL.HK. Address:

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.10 (-14.71%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0182-OL:HK CHINA WINDPOWER

N/A

N/A
0294-OL:HK YANGTZEKIANG

N/A

N/A
0346-OL:HK YANCHANG PETRO

N/A

N/A
0187-OL:HK JINGCHENG MAC

-0.40 (-12.99%)

N/A
0362-OL:HK C ZENITH CHEM

N/A

N/A
0239-OL:HK PAK FAH YEOW

-0.05 (-2.09%)

N/A

ETFs Containing 0240-OL:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -17.39% 27% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -17.39% 25% F 33% F
Trailing 12 Months  
Capital Gain -15.18% 36% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.18% 33% F 38% F
Trailing 5 Years  
Capital Gain 2.15% 69% C- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.15% 69% C- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.49% 71% C- 71% C-
Dividend Return 9.49% 68% D+ 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.92% 54% F 57% F
Risk Adjusted Return 35.25% 78% C+ 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike